WO2024156881 - CD8b-BINDING POLYPEPTIDES
National phase entry is expected:
Publication Number
WO/2024/156881
Publication Date
02.08.2024
International Application No.
PCT/EP2024/051929
International Filing Date
26.01.2024
Title **
[English]
CD8b-BINDING POLYPEPTIDES
[French]
POLYPEPTIDES DE LIAISON À CD8B
Applicants **
VIB VZW
Suzanne Tassierstraat 1
9052 Gent, BE
VRIJE UNIVERSITEIT BRUSSEL
Pleinlaan 2
1050 Brussel, BE
Inventors
VAN GINDERACHTER, Jo
c/o VIB Center for Inflammation Research
Pleinlaan 2
1050 Brussel, BE
RAES, Geert
c/o VIB Center for Inflammation Research
Pleinlaan 2
1050 Brussel, BE
VINCKE, Cécile
c/o VIB Center for Inflammation Research
Pleinlaan 2
1050 Brussel, BE
DEVOOGDT, Nick
c/o VUB
Laarbeeklaan 101
1090 Brussel, BE
DE GROOF, Timo
c/o VUB
Laarbeeklaan 101
1090 Brussel, BE
LAUWERS, Yoline
c/o VUB
Laarbeeklaan 101
1090 Brussel, BE
Priority Data
23153689.7
27.01.2023
EP
23193722.8
28.08.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1327 | |
| EPO | Filing, Examination | 5051 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 607 | |
| USA | Filing, Examination | 4510 |
Total: 12085 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention relates to polypeptides, in particular polypeptides comprising an immunoglobulin domain, binding to human and cynomolgus CD8b protein and to applications of such polypeptides such as for use as diagnostic agent, for example as an immunotracer.[French]
L'invention concerne des polypeptides, en particulier des polypeptides comprenant un domaine d'immunoglobuline, se liant à la protéine CD8b humaine et cynomolgus et des applications de tels polypeptides pour une utilisation en tant qu'agent de diagnostic, par exemple en tant qu'immunotraceur.